MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CCEL — Cryo-Cell International Inc.
NYSE AmericanCryo-Cell International Inc.
$3.99
-0.06(-1.48%)
- O
- 4.11
- H
- 4.11
- L
- 3.99
- V
- 1.49K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About CCEL
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
IndustrySERVICES-MISC HEALTH & ALLIED SERVICES, NEC
SectorNot available
IPO DateNot available
Employees76
Stock ExchangeNYSE American
Ticker SymbolCCEL
Websitehttps://www.cryo-cell.com
Key Financial Statistics
| Market Cap | $34.19M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $2.72 - $4.90 |
| 52-Week Avg Volume | 13.4K |
| VWAP | $4.09 |
| Transactions | 189 |
| Total Recorded Bars | 8,179 days |